Position in PAHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31
-$24 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 206 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUNTINGTON NATIONAL BANK holds $8,942,562 across 35 Drug Manufacturers - Specialty & Generic names. PAHC ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
78,405 | $5,634,180 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,164 | $2,256,179 | |
| 3 | VTRS |
Viatris Inc
|
17,700 | $281,075 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,001 | $271,073 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
763 | $128,596 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
2,200 | $103,994 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,129 | $81,290 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,402 | $34,503 |
All Filings in PAHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31 | 1 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $55 | 1 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $37 | 1 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $40 | 1 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,328 | 52 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $875 | 41 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $756 | 36 | Shares | Defined | 2025-02-12 | |
| 2023-03-31 | $4,289 | 280 | Shares | Defined | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||